000166201 001__ 166201
000166201 005__ 20240229133518.0
000166201 0247_ $$2doi$$a10.1093/ajcn/nqaa277
000166201 0247_ $$2pmid$$apmid:33021645
000166201 0247_ $$2ISSN$$a0002-9165
000166201 0247_ $$2ISSN$$a0095-9871
000166201 0247_ $$2ISSN$$a1938-3207
000166201 0247_ $$2ISSN$$a1938-3215
000166201 0247_ $$2altmetric$$aaltmetric:92424489
000166201 037__ $$aDKFZ-2020-02703
000166201 041__ $$aeng
000166201 082__ $$a570
000166201 1001_ $$aZamora-Ros, Raul$$b0
000166201 245__ $$aBlood polyphenol concentrations and differentiated thyroid carcinoma in women from the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
000166201 260__ $$aOxford$$bOxford University Press$$c2021
000166201 3367_ $$2DRIVER$$aarticle
000166201 3367_ $$2DataCite$$aOutput Types/Journal article
000166201 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1611322317_15622
000166201 3367_ $$2BibTeX$$aARTICLE
000166201 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000166201 3367_ $$00$$2EndNote$$aJournal Article
000166201 500__ $$aVolume 113, Issue 1, January 2021, Pages 162–171,
000166201 520__ $$aPolyphenols are natural compounds with anticarcinogenic properties in cellular and animal models, but epidemiological evidence determining the associations of these compounds with thyroid cancer (TC) is lacking.The aim of this study was to evaluate the relations between blood concentrations of 36 polyphenols and TC risk in EPIC (the European Prospective Investigation into Cancer and Nutrition).A nested case-control study was conducted on 273 female cases (210 papillary, 45 follicular, and 18 not otherwise specified TC tumors) and 512 strictly matched controls. Blood polyphenol concentrations were analyzed by HPLC coupled to tandem MS after enzymatic hydrolysis.Using multivariable-adjusted conditional logistic regression models, caffeic acid (ORlog2: 0.55; 95% CI: 0.33, 0.93) and its dehydrogenated metabolite, 3,4-dihydroxyphenylpropionic acid (ORlog2: 0.84; 95% CI: 0.71, 0.99), were inversely associated with differentiated TC risk. Similar results were observed for papillary TC, but not for follicular TC. Ferulic acid was also inversely associated only with papillary TC (ORlog2: 0.68; 95% CI: 0.51, 0.91). However, none of these relations was significant after Bonferroni correction for multiple testing. No association was observed for any of the remaining polyphenols with total differentiated, papillary, or follicular TC.Blood polyphenol concentrations were mostly not associated with differentiated TC risk in women, although our study raises the possibility that high blood concentrations of caffeic, 3,4-dihydroxyphenylpropionic, and ferulic acids may be related to a lower papillary TC risk.
000166201 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000166201 588__ $$aDataset connected to CrossRef, PubMed,
000166201 7001_ $$aLujan-Barroso, Leila$$b1
000166201 7001_ $$aAchaintre, David$$b2
000166201 7001_ $$aFranceschi, Silvia$$b3
000166201 7001_ $$aKyrø, Cecilie$$b4
000166201 7001_ $$aOvervad, Kim$$b5
000166201 7001_ $$aTjønneland, Anne$$b6
000166201 7001_ $$aTruong, Therese$$b7
000166201 7001_ $$aLecuyer, Lucie$$b8
000166201 7001_ $$aBoutron-Ruault, Marie-Christine$$b9
000166201 7001_ $$0P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4$$aKatzke, Verena$$b10$$udkfz
000166201 7001_ $$0P:(DE-He78)79ab945544e5bc017a2317b6146ed3aa$$aJohnson, Theron S$$b11$$udkfz
000166201 7001_ $$aSchulze, Matthias B$$b12
000166201 7001_ $$aTrichopoulou, Antonia$$b13
000166201 7001_ $$aPeppa, Eleni$$b14
000166201 7001_ $$aLa Vechia, Carlo$$b15
000166201 7001_ $$aMasala, Giovanna$$b16
000166201 7001_ $$aPala, Valeria$$b17
000166201 7001_ $$aPanico, Salvatore$$b18
000166201 7001_ $$aTumino, Rosario$$b19
000166201 7001_ $$aRicceri, Fulvio$$b20
000166201 7001_ $$aSkeie, Guri$$b21
000166201 7001_ $$aQuirós, J Ramón$$b22
000166201 7001_ $$aRodriguez-Barranco, Miguel$$b23
000166201 7001_ $$aAmiano, Pilar$$b24
000166201 7001_ $$aChirlaque, María-Dolores$$b25
000166201 7001_ $$aArdanaz, Eva$$b26
000166201 7001_ $$aAlmquist, Martin$$b27
000166201 7001_ $$aHennings, Joakim$$b28
000166201 7001_ $$aVermeulen, Roel$$b29
000166201 7001_ $$aWareham, Nicholas J$$b30
000166201 7001_ $$aTong, Tammy Y N$$b31
000166201 7001_ $$aAune, Dagfinn$$b32
000166201 7001_ $$aByrnes, Graham$$b33
000166201 7001_ $$aWeiderpass, Elisabete$$b34
000166201 7001_ $$aScalbert, Augustin$$b35
000166201 7001_ $$aRinaldi, Sabina$$b36
000166201 7001_ $$aAgudo, Antonio$$b37
000166201 773__ $$0PERI:(DE-600)1496439-9$$a10.1093/ajcn/nqaa277$$gp. nqaa277$$n1$$p162-171$$tThe American journal of clinical nutrition$$v113$$x1938-3207$$y2021
000166201 909CO $$ooai:inrepo02.dkfz.de:166201$$pVDB
000166201 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-09-10
000166201 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bAM J CLIN NUTR : 2018$$d2020-09-10
000166201 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-09-10
000166201 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2020-09-10
000166201 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-09-10
000166201 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2020-09-10
000166201 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-09-10
000166201 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2020-09-10
000166201 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2020-09-10
000166201 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-09-10
000166201 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-09-10
000166201 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-09-10
000166201 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bAM J CLIN NUTR : 2018$$d2020-09-10
000166201 9141_ $$y2021
000166201 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000166201 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)79ab945544e5bc017a2317b6146ed3aa$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000166201 9130_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000166201 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000166201 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000166201 980__ $$ajournal
000166201 980__ $$aVDB
000166201 980__ $$aI:(DE-He78)C020-20160331
000166201 980__ $$aUNRESTRICTED